The insulin dosage market in Slovakia experienced fluctuations from 2013 to 2023, with a notable contraction in the early years followed by a recovery. Over this period, market size, measured in million US dollars, peaked in 2020 at 73.083, with a slight decline to 72.785 by 2023. Year-on-year growth rates reveal initial declines, a rebound in 2016 and 2017, and stabilization in subsequent years. The compound annual growth rate (CAGR) over the last five years averaged 0.52%, indicating a slow overall growth.
Future trends to watch for include:
- Effects of demographic shifts and prevalence of diabetes on insulin demand.
- Healthcare policy changes impacting pricing and accessibility.
- Innovation in insulin delivery technologies fostering market growth.
How does Slovakia rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 17 | 17 Croatia | 84,861,000 | 2023 | +0.79% | -0.044% | View data |
| 18 | 18 New Zealand | 81,840,000 | 2023 | +5.78% | +2.26% | View data |
| 19 | 19 Slovakia | 72,785,000 | 2023 | -0.13% | +0.52% | |
| 20 | 20 Ireland | 58,009,000 | 2023 | -0.15% | -0.85% | View data |
| 21 | 21 Switzerland | 53,245,000 | 2023 | -2.3% | -1.88% | View data |
